FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386935009: Tazarotene (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461113015 Tazarotene (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481049014 Tazarotene en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tazarotene Is a Retinoid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing tazarotene Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Tazarotene 0.1% gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% aqueous gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% aqueous gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% cream Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% cream Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Product containing precisely tazarotene 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel Has basis of strength substance True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel Has precise active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel Has basis of strength substance True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 1 milligram/1 gram conventional release cutaneous gel Has precise active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing tazarotene in cutaneous dose form (medicinal product form) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Tazarotene Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing only tazarotene in cutaneous dose form (medicinal product form) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has basis of strength substance True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has precise active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has precise active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has basis of strength substance True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing halobetasol and tazarotene (medicinal product) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing halobetasol and tazarotene in cutaneous dose form (medicinal product form) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing only halobetasol and tazarotene (medicinal product) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Product containing only halobetasol and tazarotene in cutaneous dose form (medicinal product form) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier 1
Tazarotene 0.05% aqueous gel - product Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% aqueous gel - product Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% aqueous gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% aqueous gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% gel (Allergan Ltd) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel 30 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel 60 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel 30 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel 60 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) 30 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) 60 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% gel (Allergan Ltd) 30 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% gel (Allergan Ltd) 60 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc) Has active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc) 30 gram Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) 60 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel 60 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% aqueous gel Has specific active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Allergan Ltd) 30 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc) Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel 30 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.05% gel (Sigma Pharmaceuticals Plc) 30 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% gel (Allergan Ltd) Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% gel (Allergan Ltd) 30 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel 30 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel 60 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% aqueous gel Has specific active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Zorac 0.1% gel (Allergan Ltd) 60 gram Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has specific active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel Has specific active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.05% gel Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel Has active ingredient False Tazarotene Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel Has specific active ingredient True Tazarotene Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start